+ Filter
Loading...
LYPD3
Anti-LYPD3 Recombinant Antibody Products
CompareMore Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
C4.4A (LYPD3) has been identified as a cancer- and metastasis-associated internalizing cell surface protein that is expressed in non-small cell lung cancer (NSCLC), with particularly high prevalence in the squamous cell carcinoma (SCC) subtype.
Predicted location
Membrane
Single cell type specificity
Cell type enhanced (Suprabasal keratinocytes, Squamous epithelial cells, Syncytiotrophoblasts, Urothelial cells, Basal keratinocytes)
Immune cell specificity
Immune cell enhanced (naive CD4 T-cell)
Cell line specificity
Cell line enhanced (CAPAN-2, HaCaT, MCF7, RT4, SK-BR-3)
Interaction
Binds laminin-1 and laminin-5. Interacts with LGALS3 (By similarity). Interacts with AGR2 and AGR3.
More Types Infomation